In this Critical Perspective, we discuss a central limitation of current Model-Informed Precision Dosing in critically ill patients: many dosing decisions are still based on intermittent snapshots of a physiology that is continuously changing
Estrogen has been shown to upregulate endogenous MOTS-c expression in preclinical models, which may partly explain why metabolic deterioration accelerates in perimenopause when estrogen falls precipitously [2]
TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities
A premier triple-agonist research peptide (GLP-1, GIP, and Glucagon) for investigating intensive metabolic regulation, energy expenditure, and liver health
How much weight can patients lose on tirzepatide
The lack of regulatory oversight raises concerns about the consistency and reliability of compounded medications